Lymphocyte Depleted Hodgkin Lymphoma, Lymph Nodes of Multiple Sites (C81.38)

Name of the Condition

• Common Name: Lymphocyte Depleted Hodgkin Lymphoma, Lymph Nodes of Multiple Sites
• Medical Terms: LD Hodgkin Lymphoma, Lymphocyte-Depleted Hodgkin Disease (multiple lymph node sites)

Summary

Lymphocyte depleted Hodgkin lymphoma (LD Hodgkin lymphoma) is a rare and aggressive subtype of Hodgkin lymphoma. It is characterized by a scarcity of lymphocytes and a predominance of Reed-Sternberg cells in affected lymph nodes or tissues. This subtype often presents at an advanced stage and may involve extranodal sites, such as the liver or bone marrow. LD Hodgkin lymphoma is associated with a poorer prognosis compared to other Hodgkin lymphoma subtypes, though treatment advances have improved outcomes.

Causes

The exact cause of lymphocyte depleted Hodgkin lymphoma is not fully understood. It is thought to result from a combination of genetic mutations and environmental factors. Unlike other Hodgkin lymphoma subtypes, Epstein-Barr virus (EBV) is frequently associated with LD Hodgkin lymphoma, suggesting a potential viral role in its development. Genetic abnormalities and immune system dysregulation may also contribute.

Risk Factors

• Age: Most commonly diagnosed in adults, particularly those over 50.
• Immune Status: Weakened immunity (e.g., from HIV/AIDS or immunosuppressive therapy) increases risk.
• Epstein-Barr Virus: Prior infection is strongly associated with this subtype.
• Geographic Region: Higher incidence in certain regions, possibly due to environmental or genetic factors.

Symptoms

• Painless swelling of lymph nodes in multiple areas (e.g., neck, armpits, groin).
• Persistent fatigue or weakness.
• Unexplained weight loss.
• Fever, night sweats, or chills (B symptoms).
• Loss of appetite.
• Itching (pruritus) or skin rashes.
• In advanced cases, symptoms related to organ involvement (e.g., abdominal pain, breathing difficulties).

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A biopsy of an affected lymph node is essential to confirm the presence of Reed-Sternberg cells and assess lymphocyte depletion. Imaging studies (e.g., CT, PET scans) help determine the extent of disease and identify multiple lymph node involvement. Blood tests may evaluate overall health and detect abnormalities like elevated erythrocyte sedimentation rate or anemia. Staging is performed to classify the disease and guide treatment.

Treatment Options

Treatment typically involves chemotherapy, often combined with radiation therapy for localized disease. Common regimens include ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) or more intensive protocols for advanced cases. Stem cell transplantation may be considered for relapsed or refractory disease. Immunotherapy (e.g., checkpoint inhibitors) is being explored for select patients. Treatment plans are individualized based on disease stage, patient health, and response to initial therapy.

Prognosis and Follow-Up

Prognosis for lymphocyte depleted Hodgkin lymphoma is generally poorer than other subtypes, but outcomes have improved with modern therapies. Survival rates depend on disease stage, patient age, and response to treatment. Regular follow-up is critical to monitor for recurrence, manage long-term side effects (e.g., secondary cancers, heart or lung issues), and address any new symptoms. Lifelong surveillance may be recommended.

Complications

• Disease progression or relapse.
• Treatment-related toxicities (e.g., infertility, organ damage).
• Secondary malignancies (e.g., leukemia, non-Hodgkin lymphoma).
• Infections due to weakened immunity.
• Psychological distress or emotional challenges.

Lifestyle & Prevention

• Maintain a balanced diet and regular exercise to support overall health.
• Avoid smoking and limit alcohol consumption.
• Practice good hygiene to reduce infection risk.
• Stay up-to-date with vaccinations (as recommended by a healthcare provider).
• Seek emotional support through counseling or support groups.

When to Seek Professional Help

Consult a healthcare provider if you experience persistent lymph node swelling, unexplained weight loss, fever, or other symptoms of Hodgkin lymphoma. Early evaluation is important for timely diagnosis and treatment. Seek immediate care for severe symptoms, such as difficulty breathing, chest pain, or signs of infection (e.g., high fever, confusion).

Tips for Medical Coders

Use code C81.38 for lymphocyte depleted Hodgkin lymphoma involving lymph nodes of multiple sites. Ensure documentation specifies the number and location of affected lymph node regions to support code assignment. Differentiate from codes for single-site or extranodal involvement. Verify that the diagnosis aligns with histopathological confirmation of Reed-Sternberg cells and lymphocyte depletion.